A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Pfizer
Pfizer
Pfizer
Nested Therapeutics, Inc
Ikena Oncology
Eli Lilly and Company
National Cancer Institute (NCI)
Deciphera Pharmaceuticals, LLC
M.D. Anderson Cancer Center
Polaris Group
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Duke University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
TransMolecular